Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Hassan AbolghasemiSamira Shahverdi

Abstract

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life of several hundred thousand worldwide. However, so far no approved vaccine or drug therapy is available for treatment of virus infection. Convalescent plasma has been considered a potential modality for COVID-19 infection. One hundred eighty-nine COVID-19 positive patients including 115 patients in plasma therapy group and 74 patients in control group, registered in the hospitals with confirmed COVID-19 infection, entered this multi-center clinical study. Comparison of outcomes including all-cause mortality, total hospitalization days and patients' need for intubation between the two patient groups shows that total of 98 (98.2 %) of patients who received convalescent plasma were discharged from hospital which is substantially higher compared to 56 (78.7 %) patients in control group. Length of hospitalization days was significantly lower (9.54 days) in convalescent plasma group compared with that of control group (12.88 days). Only 8 patients (7%) in convalescent plasma group required intubation while that was 20 % in control group. This clinical study provides strong evidence to support the efficacy of convalescent plasma therapy in COVID-19...Continue Reading

Citations

Sep 17, 2020·BMJ : British Medical Journal·Lise J Estcourt, David J Roberts
Aug 8, 2020·Clinical Transplantation·Paolo CravediJamil Azzi
Sep 29, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai
Sep 24, 2020·Human Vaccines & Immunotherapeutics·Ankur GuptaShailendra K Saxena
Oct 13, 2020·The Cochrane Database of Systematic Reviews·Khai Li ChaiNicole Skoetz
Sep 27, 2020·Transfusion·Christof JungbauerThomas R Kreil
Nov 5, 2020·Expert Review of Clinical Immunology·Isabelle AmiguesMaximilian Konig
Oct 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shuai ShaoZhaohui Tong
Nov 2, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Daniele Focosi, Albert Farrugia
Nov 16, 2020·International Immunopharmacology·Arun KumarVishal Aggarwal
Feb 6, 2021·Journal of Clinical Apheresis·Charan T R VegivintiAmeer E Hassan
Dec 31, 2020·Journal of Clinical Medicine·Anna Moniuszko-MalinowskaRobert Flisiak
Nov 17, 2020·SN Comprehensive Clinical Medicine·Nevio Cimolai
Feb 11, 2021·Clinical Microbiology Newsletter·Juan G RipollMichael J Joyner
Feb 2, 2021·The New England Journal of Medicine·Michael J JoynerArturo Casadevall
Feb 13, 2021·Biologics : Targets & Therapy·Massimo Franchini, Giancarlo Maria Liumbruno
Feb 24, 2021·Expert Review of Clinical Immunology·Deniz Cagdas
Feb 20, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Adam TworekGrażyna Rydzewska
Feb 24, 2021·Blood Cells, Molecules & Diseases·Sandeep BudhirajaRahul Naithani
Mar 18, 2021·ImmunoTargets and Therapy·Amal HasanFahd Al-Mulla
Mar 19, 2021·The Cochrane Database of Systematic Reviews·Lina GhosnIsabelle Boutron
Sep 26, 2020·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Evan M BlochAaron A R Tobian
Mar 26, 2021·Frontiers in Pharmacology·Omkar IndariHem Chandra Jha
Mar 23, 2021·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Manya PrasadArunmozhimaran Elavarasi
Apr 8, 2021·JMIR Public Health and Surveillance·Henry T PengAndrew Beckett
Apr 24, 2021·Microbial Cell Factories·Norma A Valdez-CruzMauricio A Trujillo-Roldán
Apr 27, 2021·SN Comprehensive Clinical Medicine·Christina ChanNeil T Wright
Apr 27, 2021·Frontiers in Medicine·Vikas BansalRahul Kashyap
May 8, 2021·Journal of Global Health·Yijia DongEvropi Theodoratou
May 4, 2021·Frontiers in Immunology·Mateo Chvatal-MedinaMaria T Rugeles
May 21, 2021·The Cochrane Database of Systematic Reviews·Vanessa PiechottaNicole Skoetz
May 27, 2021·Transfusion·Jonathon W SenefeldMichael J Joyner
May 18, 2021·Clinical Epidemiology and Global Health·Shinta Oktya WardhaniHarapan Harapan

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Fevzi AltuntasMehmet Ali Erkurt
Proceedings of the National Academy of Sciences of the United States of America
Furong ZengGuangtong Deng
BMJ : British Medical Journal
Lise Estcourt, David J Roberts
JAMA : the Journal of the American Medical Association
Anurag N MalaniPreeti N Malani
© 2021 Meta ULC. All rights reserved